Anal sac adenocarcinoma in dogs.

What it is

Anal sac adenocarcinoma (ASAC, also called apocrine gland adenocarcinoma of the anal sac) is a malignant tumor arising from one of the paired sacs that flank the dog's anus. The tumor tends to be locally invasive, spreads to regional sublumbar (medial iliac) lymph nodes early, and can metastasize further with time.

A characteristic feature: ASAC secretes parathyroid hormone-related protein (PTHrP) in many cases, causing hypercalcemia of malignancy — which can produce symptoms (increased thirst, weakness, vomiting) before the tumor itself is large enough to cause local discomfort.

Signs to watch for

• Scooting, straining to defecate, or ribbon-like stools. From local tumor mass or enlarged lymph nodes pressing on the rectum.
• A noticeable mass near the anus (more obvious in shorter-coated breeds).
• Increased thirst, increased urination, weakness, or vomiting. Possible signs of hypercalcemia.
• Loss of appetite or weight loss.

How veterinarians diagnose it

A rectal exam — part of any thorough physical — is the most reliable initial screen, especially in older dogs. ASAC is one of the strongest arguments for keeping that exam on the wellness checklist.

FNA + cytology of a suspect mass is highly diagnostic. Bloodwork including ionized calcium is essential because of the hypercalcemia association.

Staging: abdominal ultrasound or CT to evaluate sublumbar lymph nodes (commonly involved at diagnosis), three-view chest radiographs or thoracic CT, and bloodwork.

What treatment usually looks like

• Surgical resection of the primary tumor (anal sacculectomy) is the foundation of treatment when feasible.
• Removal of involved sublumbar lymph nodes (retroperitoneal lymphadenectomy) when imaging shows enlargement — this is technically demanding and best done at a referral center.
• Adjuvant chemotherapy (carboplatin, mitoxantrone, or toceranib) is commonly recommended given the high rate of micrometastasis.
• Radiation therapy as an adjunct for incompletely excised primary tumors or bulky lymph node disease.
• Management of hypercalcemia with IV fluids, furosemide, and sometimes bisphosphonates when calcium is dangerously elevated.

Prognosis

Published median survival with surgery plus chemotherapy ranges widely depending on stage at diagnosis, completeness of surgical resection, and presence of distant metastasis — often in the range of one to two years from diagnosis for surgically resected cases, with considerable individual variation.

Hypercalcemia at presentation is associated with worse prognosis but is not necessarily a contraindication to definitive therapy if managed promptly.

Questions to ask your vet

• How extensive is the local disease? Are the sublumbar lymph nodes involved?
• Is my dog hypercalcemic? Do we need IV fluids first?
• Is the tumor and any involved lymph nodes resectable at our clinic or do we need a referral surgeon?
• What's the recommended chemotherapy protocol?
• How often should we re-image to catch recurrence?

Where to learn more

Veterinary teaching hospitals at most accredited US vet schools maintain owner-facing fact sheets on common cancers. Peer-reviewed journals — JAVMA, Veterinary and Comparative Oncology, Frontiers in Veterinary Science — are accessible through PubMed. The American College of Veterinary Internal Medicine (ACVIM) and the Veterinary Cancer Society publish consensus statements you can ask your vet to walk you through.

For clinical trials enrolling dogs with this diagnosis, see the SciRouter Vet trial finder — we index AVMA, NCI COTC, and twelve university registries.